Eli Lilly and Company (LLY)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Strong 4/5 metrics rated Sunny
What does Eli Lilly and Company do?
💊 Eli Lilly and Co. is a global pharmaceutical company that develops and markets medicines for various health conditions. Their innovative products like insulin for diabetes, treatments for cancer, arthritis, mental health, and more make them a champion in the healthcare industry. 🌐 Headquartered in Indianapolis, Indiana, they've been at the forefront of medical advancements since 1876..
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ☀️ Strong | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ⛅ Moderate | Balance sheet strength |
| Price | $1160.08 | Market Cap | — |
| Exchange | New York Stock Exchange | | |
Plain-English Analysis
What's it worth?
Based on 5-year performance trends, Eli Lilly and Company has historically delivered strong returns. Sign up free for full valuation analysis including P/E, DCF estimates, and Stockbruh's plain-English take on whether this stock looks cheap or expensive right now.
Are they building the future?
Revenue and earnings are trending upward — Eli Lilly and Company appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.